As of 2025-10-19, the Relative Valuation of WAVE Life Sciences Ltd (WVE) is (8.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.81 USD, the upside of WAVE Life Sciences Ltd based on Relative Valuation is -208.6%.
The range of the Relative Valuation is (7.83) - (10.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.7x - 13.1x | 9.4x |
| Forward P/E multiples | 9.6x - 13.2x | 11.4x |
| Fair Price | (7.83) - (10.68) | (8.48) |
| Upside | -200.3% - -236.8% | -208.6% |
| Date | P/E |
| 2025-10-16 | -9.65 |
| 2025-10-15 | -9.92 |
| 2025-10-14 | -9.67 |
| 2025-10-13 | -9.55 |
| 2025-10-10 | -9.32 |
| 2025-10-09 | -10.04 |
| 2025-10-08 | -9.01 |
| 2025-10-07 | -8.82 |
| 2025-10-06 | -8.85 |
| 2025-10-03 | -8.77 |
| 2025-10-02 | -8.61 |
| 2025-10-01 | -8.62 |
| 2025-09-30 | -8.97 |
| 2025-09-29 | -8.74 |
| 2025-09-26 | -8.34 |
| 2025-09-25 | -8.17 |
| 2025-09-24 | -8.25 |
| 2025-09-23 | -8.37 |
| 2025-09-22 | -8.47 |
| 2025-09-19 | -8.45 |
| 2025-09-18 | -8.53 |
| 2025-09-17 | -8.34 |
| 2025-09-16 | -8.36 |
| 2025-09-15 | -8.55 |
| 2025-09-12 | -8.55 |
| 2025-09-11 | -8.78 |
| 2025-09-10 | -9.06 |
| 2025-09-09 | -9.17 |
| 2025-09-08 | -9.29 |
| 2025-09-05 | -10.16 |
| 2025-09-04 | -10.03 |
| 2025-09-03 | -9.81 |
| 2025-09-02 | -11.79 |
| 2025-08-29 | -11.77 |
| 2025-08-28 | -12.17 |
| 2025-08-27 | -12.36 |
| 2025-08-26 | -12.22 |
| 2025-08-25 | -12.19 |
| 2025-08-22 | -12.44 |
| 2025-08-21 | -11.97 |
| 2025-08-20 | -11.59 |
| 2025-08-19 | -11.66 |
| 2025-08-18 | -11.94 |
| 2025-08-15 | -11.97 |
| 2025-08-14 | -10.92 |
| 2025-08-13 | -10.74 |
| 2025-08-12 | -10.36 |
| 2025-08-11 | -9.94 |
| 2025-08-08 | -9.92 |
| 2025-08-07 | -9.97 |